SGLT2 inhibition: What are the potential mechanisms for clinical benefit?
Presentation prepared and held by Prof Hiddo Lambers Heerspink, MD, University Medical Centre Groningen, The Netherlands at the CME accredited 'Asian Cardio Diabetes Forum' held on April 23-24, 2016 in Kuala Lumpur, Malaysia.
The presentation is provided as an educational service to registered members only
SGLT2 inhibition. What are the potential mechanisms of benefit. prof Lambers Heerspink.pdf (1,5MB)
The presentation is provided as an educational service to registered members only
Download as PDF
SGLT2 inhibition. What are the potential mechanisms of benefit. prof Lambers Heerspink.pdf (1,5MB)
View slides, click on images
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
Share this page with your colleagues and friends: